Generation of hypoxia-sensing chimeric antigen receptor T cells

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
91 Downloads (Pure)


Exploiting hypoxia in solid malignancies to restrict expression of chimeric antigen receptors (CARs) on engineered T cells to the tumor microenvironment overcomes the risk of on-target off-tumor toxicity and minimizes tonic signaling, which promotes CAR T cell exhaustion. This protocol summarizes the synthetic biology underlying the development of a stringent oxygen-sensitive CAR for in vitro and in vivo preclinical characterization. For complete details on the use and execution of this protocol, please refer to Kosti et al. (2021).
Original languageEnglish
Article number100723
JournalSTAR Protocols
Issue number3
Publication statusPublished - 17 Sept 2021


Dive into the research topics of 'Generation of hypoxia-sensing chimeric antigen receptor T cells'. Together they form a unique fingerprint.

Cite this